TerminatedNCT00600743
Effect of a CCK-1R Agonist on Food Intake in Humans
Medication studyAges 18–45United StatesEating disorders
Understand this study
Who could participate?
Listed age limits: 18 years to 45 years.
- Listed locations
- New YorkSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateJanuary 2008
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 40
- Sponsor
- St. Luke's-Roosevelt Hospital Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Behavioral
- Intervention type
- Psychotherapy / behavioral intervention, Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 45 Years
- Official registry ID
- NCT00600743
- Official title
Show the full official title
Effect of a CCK-1R Agonist on Food Intake in Humans
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
New York
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is St. Luke's-Roosevelt Hospital Center, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including GSKI181771X (CCK-1R agonist) and Placebo.
Who can participate?
Listed age limits: 18 years to 45 years.
Is this study still recruiting?
The registry lists this study as terminated.
